Octean Pharma ApS: Financial statements 2020
CVR: 38023667
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
Octean Pharma ApS (CVR 38023667) has filed annual accounts for 2020. In 2020, the company reported revenue of DKK 1,330,642 and a net result of DKK 11,061 compared with DKK 50,720 the year before. That is an increase of 18.1% compared with the year before. The profit margin was 0.8%. Equity in the 2020 report amounted to DKK 47,177. The solvency ratio was 7%. The company had 1 employee in the financial year.
- Revenue
- DKK 1,330,642
- Gross Profit
- DKK 793,230
- Profit/Loss
- DKK 11,061
- Equity
- DKK 47,177
- Total Assets
- DKK 671,888
- Employees
- 1
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | 1.3 mio. | 793 t. | 11 t. | 47 t. | 1 |
| 2019 | 1.1 mio. | 751 t. | 51 t. | 36 t. | - |
| 2018 | 844 t. | 584 t. | 97 t. | -15 t. | - |
Official annual report
How creditworthy is Octean Pharma ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
Octean Pharma ApS has published its annual report for 2019. Revenue came to DKK 1,126,618, and the net result was DKK 50,720.
About Octean Pharma ApS
Octean Pharma ApS is a Danish company of the type Anpartsselskab based in Skanderborg, founded in 2016. The company is registered under the industry Detailhandel med andre fødevarer. The management consists of Lotte Johannesson. The company is owned by Halobid Aktiebolag. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -14,152 and a net result of DKK -15,398 compared with DKK 102,485 the year before. Equity in the 2025 report amounted to DKK 206,750.